Skip to main content

Select Drug Profiles

Original Research
Measuring the Value of Treatment to Patients: Patient-Reported Outcomes in Drug Development
Richard J. Willke, PhD
Stakeholder Perspective
AHDB Stakeholder Perspective
Read More
FDA Approvals
Approvable Letters in 2007 and the Outlook for 2008
Mark Senak, JD
Read More
Practice Management
The 2007 Pharmaceutical and Biotech Pipeline Year-End Summary: What it Says About the State of the Art of Discovery & Development
Michael F. Murphy, MD, PhD
Read More
Perspectives
Contracting for Compliance: Using Adherence as a Patient-Centered Measure of Performance
Scott R. Taylor, RPh, MBA, J. B. Jones, PhD, MBA, Nirav R. Shah, MD,MPH
Read More
Practice Management
Wayward Prescriptions: Costs of Fraud in Payor Plans
Thomas Kaye, RPh, MBA, FASHP
Stakeholder Perspective
Procedures Needed to Prevent Prescription Fraud
by Susan Sarnoff, DSW
Read More
Bustling Pipeline for Diabetes and Its Metabolic Consequences
Wayne Kuznar
Read More
Practice Management
FDA Bolsters Its Generic Approval Process: Health Plans Reap the Benefits
Read More
FDA Approvals
Heparin at the Center of the Storm
Mark Senak, JD
Read More
Original Research
Prescribing Warfarin Appropriately to Meet Patient Safety Goals
Lekshmi Dharmarajan, MD, FACP, FACC, T. S. Dharmarajan, MD, FACP, AGSF
Stakeholder Perspective
Benefits of Genetic Testing in Warfarin Therapy
by Teresa DeLuca, MD, MBA
Read More
Practice Management
Treading Water: The No-Growth Investment in Health Services Research
Emily J. Holubowich, MPP, Joseph R. Antos, PhD
Stakeholder Perspective
The Golden Age of Health Services Research
by Joseph R. Antos, PhD
Read More
Page 233 of 244
Results 2321 - 2330 of 2434